The revolutionary LaViv procedure from Dr. Daniel Behroozan
In comparison to other facial volume enhancement treatments, Juvederm and Restylane treatments have been considered the most efficacious anti-aging system offered to date. This has changed, however, since the latest filler treatment alternative, known as LaViv, was recently approved by FDA. This new treatment, offered by Los Angeles Dermatologist Dr. Daniel Behroozan, is the latest anti-wrinkle pharmaceutical therapy to challenge the efficacy Botox and Filler treatments.
Reason for its approval from FDA
One of the main reasons that the FDA approved the use of LaViv is that it provides scientifically proven results in combating the aging process. The major of this new treatment is that the patient’s OWN CELLS are used for restoring volume. In addition, after the cells are expanded in a laboratory, the patient then has a long lasting supply of cells for filling.